Back
Penumbra 10K Form
Buy
71
PEN
Penumbra
Last Price:
209.95
Seasonality Move:
8.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-03 | 10Q | PEN/Penumbra Quarterly |
| 2020-05-07 | 10Q | PEN/Penumbra Quarterly |
| 2020-02-26 | 10K | PEN/Penumbra Annual |
| 2019-11-07 | 10Q | PEN/Penumbra Quarterly |
| 2019-08-06 | 10Q | PEN/Penumbra Quarterly |
| 2019-05-07 | 10Q | PEN/Penumbra Quarterly |
Receive PEN News And Ratings
See the #1 stock for the next 7 days that we like better than PEN
PEN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.06B |
|---|---|
| Cash Flow: | $32.62M |
| Price / Cash Flow: | 101.02 |
| Annual Sales: | $30.48 |
| Price / Book: | 6.96 |
Profitability
| EPS (TTM): | 2.31000 |
|---|---|
| Net Income (TTM): | $90.95M |
| Gross Margin: | $682.64M |
| Return on Equity: | 8.46% |
| Return on Assets: | 6.3% |
Penumbra Earnings Forecast
Key Penumbra Financial Ratios
- The Gross Profit Margin over the past 12 years for PEN is 64.49%.
- The Selling, General & Administrative Expenses for PEN have been equal to 47.85% of Gross Profit Margin.
- The Research & Development expenses have been 7.98% of Revenue.
- The Interest Expense is 1.91% of Operating Income.
- The Net Earning history of PEN is 8.59% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Penumbra Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | PEN |
| CUSIP: | 70975L |
| Website: | penumbrainc.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.06 |
| Quick Ratio: | 3.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 91.22 |
|---|---|
| Forward P/E Ratio: | 55.01 |